DOI 10.1007/s11845-025-03977-6
Enhanced diagnostic accuracy of type 1 diabetes mellitus through the combined use of serum β-catenin and HbA1c.
Аннотация
BACKGROUND
Type 1 diabetes mellitus (T1DM) is due to the autoimmune destruction of pancreatic β-cells. Biomarkers of early diagnosis of T1DM are important to improve treatment and prevent complications. β-catenin, a key effector of the WNT signaling pathway, plays a critical role in the development of pancreatic β-cells. This study investigates the association between serum β-catenin protein and T1DM and evaluates its diagnostic performance compared to routine markers.
MATERIAL AND
METHODS
The study included 50 patients with T1DM aged 15-25 years and 30 healthy age- and gender-matched subjects (HS). All participants were evaluated with full history taking, thorough clinical examination, and laboratory evaluation of biochemical tests and glycemic markers. Serum β-catenin was measured using an enzyme-linked immunosorbent assay.
RESULT: There were significant differences in the concentration of β-catenin between T1DM and HS (P < 0.001). Gender, HbA1c, BU, and lipid profile were found to be significantly independently related to β-catenin levels (P < 0.05). β-catenin showed excellent discriminatory ability (AUC 1.0); the results revealed that the best cut-off value of β-catenin levels to predict T1DM was > 1.81 ng/ml.
CONCLUSION
The results show that the concentration of β-catenin has the potential to diagnose T1DM. Further, larger studies are needed on whether β-catenin has a therapeutic role in T1DM.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.